Evidence map›Paper›PMID 39012548›Full record

ReviewCurrent cardiology reports2024

Cardiac Sarcoidosis: Utilizing Cardiac MRI and PET-CT.

Kamari Ositelu, Sonu Abraham, Ike S Okwuosa

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kamari OsiteluNorthwestern University, Feinberg School of Medicine, Division of Cardiology, Chicago, IL, USA.
Sonu AbrahamNorthwestern University, Feinberg School of Medicine, Division of Cardiology, Chicago, IL, USA.
Ike S OkwuosaNorthwestern University, Feinberg School of Medicine, Division of Cardiology, Chicago, IL, USA. Ike.Okwuosa@nm.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeof reviewCardiac sarcoidosis is an inflammatory condition that has been associated with deleterious cardiac manifestations. The diagnosis of cardiac sarcoidosis is challenging and can be guided by advanced cardiac imaging. RECENT

findingsEndomyocardial biopsy lacks sensitivity in confirming a diagnosis of cardiac sarcoidosis. Studies have shown that the use of cardiac magnetic resonance imaging (MRI) and cardiac Positron Emission Testing (PET) are associated with increased sensitivity and specificity in the diagnosis of cardiac sarcoidosis. Cardiac MRI and cardiac PET CT, although distinct entities, are complimentary in the diagnosis, prognostication of major cardiac events, and aid in the treatment algorithm in patients with cardiac sarcoidosis.

Indexed as

CardiomyopathiesMagnetic Resonance ImagingPositron Emission Tomography Computed TomographySarcoidosisHumansMyocardiumPrognosisSensitivity and SpecificityCardiac MRCardiac sarcoidosisPET-CTSarcoidosis

Identifiers

PMID39012548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.